TES Antibody, HRP conjugated

Shipped with Ice Packs
In Stock

Description

Definition and Purpose

The TES Antibody, HRP conjugated, refers to an immunological reagent where a primary antibody targeting the TES (Thymocyte-expressed, positive Selection-associated) protein is covalently linked to horseradish peroxidase (HRP), an enzyme used as a reporter molecule. This conjugate enables detection of TES protein in assays like ELISA, immunohistochemistry (IHC), and western blotting via chromogenic or chemiluminescent reactions .

Conjugation Methods

HRP conjugation to antibodies typically involves oxidizing HRP’s carbohydrate residues using sodium periodate to generate aldehyde groups, which react with lysine residues on the antibody. A modified protocol, incorporating lyophilization, enhances conjugation efficiency by reducing reaction volume while preserving enzymatic activity .

Conjugation MethodKey FeaturesOutcome
Traditional (Periodate)Oxidizes HRP’s carbohydratesLower binding efficiency, requires higher antibody dilution (1:25)
Modified (Lyophilized)Includes lyophilization stepHigher sensitivity (1:5000 dilution), improved stability

Applications

  • ELISA: Detects TES protein in serum or tissue lysates using substrates like TMB or luminol .

  • IHC: Visualizes TES localization in tissue sections via DAB staining .

  • Western Blotting: Enhances signal intensity for TES protein detection .

Research Findings

A study comparing traditional and modified conjugation methods demonstrated that the lyophilized HRP-antibody conjugate achieved 96% activity retention versus 70% for the classical method . ELISA sensitivity improved by 200-fold, with a statistically significant difference (p < 0.001) in antigen detection .

ParameterTraditional MethodModified Method
Antibody Dilution1:251:5000
Signal IntensityModerateHigh
Stability2 months at 4°C6 months at 4°C

Advantages Over Alternatives

HRP-conjugated antibodies offer faster reaction times and lower costs compared to alkaline phosphatase (AP) conjugates. HRP’s smaller size (44 kDa) also reduces steric hindrance, improving binding efficiency .

Future Directions

Optimization of conjugation protocols for poly-HRP labeling and validation across diverse IgG subclasses remain critical areas of research . Industrial scalability and long-term storage stability studies are needed to broaden diagnostic applications .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your order. The delivery time may vary depending on the purchasing method or location. Please consult your local distributor for specific delivery time information.
Synonyms
DKFZP586B2022 antibody; MGC1146 antibody; TES antibody; TES_HUMAN antibody; TESS 2 antibody; TESS antibody; TESS2 antibody; Testin antibody; Testis derived transcript (3 LIM domains) antibody; Testis derived transcript antibody
Target Names
TES
Uniprot No.

Target Background

Function
Testin (TES) is a scaffold protein potentially involved in cell adhesion, cell spreading, and the reorganization of the actin cytoskeleton. It plays a role in regulating cell proliferation. Furthermore, TES may act as a tumor suppressor, inhibiting tumor cell growth.
Gene References Into Functions
  1. Two novel TES cocomplex partners have been validated: TGFB1I1 and a short form of the glucocorticoid receptor. TES and TGFB1I1 demonstrate opposing effects on cell spreading, providing biological validity for their copresence in complexes as they function in similar processes. PMID: 28378594
  2. Research suggests that TES acts as a necessary suppressor of colorectal cancer progression by activating p38-MAPK signaling pathways. PMID: 27323777
  3. The testin region (amino acids 52-233) containing the PET domain interacts with the C-terminal LIM1-2 domains. PMID: 28542564
  4. Testin plays a significant role in the development and progression of non-small cell lung cancer. It has been identified as a tumor suppressor. PMID: 28000866
  5. VASP, zyxin, and TES are tension-dependent members of focal adherens junctions independent of the alpha-catenin-vinculin module. PMID: 26611125
  6. Studies confirm that the TES promoter remains unmethylated in normal adult and fetal tissues. Re-expression of TESTIN protein in acute lymphoblastic leukemia cells using expression plasmid transfection results in rapid cell death or cell cycle arrest. PMID: 26985820
  7. Loss of TES gene expression has been linked to nasopharyngeal carcinoma. PMID: 25824796
  8. Research findings suggest that the TES gene is a novel tumor suppressor gene. PMID: 25498217
  9. TESTIN was found to be hypermethylated in 43.7% of endometrial cancer tissues (p < 0.001). Furthermore, TESTIN hypermethylation was significantly correlated with advanced tumor stage, deep myometrial invasion, and lymphatic node metastasis. PMID: 25720371
  10. Downregulation of TES has been associated with breast cancer. PMID: 25119600
  11. TESTIN was commonly downregulated in human endometrial carcinoma and was associated with poor prognostic markers. PMID: 24929083
  12. A further significant correlation was observed between TES downregulation and the luminal B subtype independent of survivin expression. PMID: 23715752
  13. TES, as a valuable marker of breast cancer prognosis, plays an important role in the development and progression of breast cancer. TES may be an effective novel target for breast cancer prevention and treatment. PMID: 22957844
  14. Low TES gene expression is associated with coronary artery disease. PMID: 22156939
  15. Alterations in TES mRNA level may predict the location of metastasis. CAV1 potentially affects the cancer cell invasion. PMID: 22201996
  16. These results suggest an interplay between the CaR and testin in the regulation of CaR-mediated Rho signaling with possible effects on the cytoskeleton. PMID: 21843504
  17. Data implicate TES methylation in ALL and provide additional evidence for the involvement of LIM domain proteins in leukaemogenesis. PMID: 20573277
  18. Results support the role of TES as a TSG in gastric carcinogenesis and that TES is inactivated primarily by LOH and CpG island methylation. PMID: 20626849
  19. The expression level of TES is significantly down-regulated in primary gastric cancer. PMID: 18799041
  20. The TES gene functions as a tumor suppressor gene and is frequently silenced by hypermethylation and loss of heterozygosity in ovarian cancers. PMID: 20180808
  21. TES is a prime candidate tumor suppressor gene at 7q31 in prostate tumors. PMID: 15252854
  22. Loss of TES from focal adhesions results in loss of actin stress fibers. PMID: 15662727
  23. Observations identify Tes as an atypical binding partner of the EVH1 domain of Mena and a regulator specific to a single Ena/VASP family member. PMID: 18158903
  24. Results suggest that testin has different conformational states in different cellular compartments, and a "closed" conformational state of TES may be involved in nucleolar localization. PMID: 18696217
  25. Inactivation of TESTIN is involved in head and neck carcinogenesis through its downregulation. PMID: 19289703

Show More

Hide All

Database Links

HGNC: 14620

OMIM: 606085

KEGG: hsa:26136

STRING: 9606.ENSP00000350937

UniGene: Hs.592286

Protein Families
Prickle / espinas / testin family
Subcellular Location
Cytoplasm. Cell junction, focal adhesion. Note=Detected along actin stress fibers.
Tissue Specificity
Ubiquitous.

Q&A

What is the molecular structure of HRP when conjugated to antibodies?

HRP is a glycoprotein with a molecular weight of approximately 44 kDa containing around 18% carbohydrate content surrounding a protein core. When conjugated to antibodies (typically ~150 kDa for IgG), the conjugate maintains both the enzymatic activity of HRP and the binding specificity of the antibody. The average ratio of HRP:antibody is typically 2-4 HRP molecules per antibody molecule, resulting in a theoretical average molecular weight of 238-326 kDa for the complete conjugate . UV-spectrophotometry analysis of HRP-antibody conjugates typically shows characteristic peaks at both 280 nm (antibody) and 430 nm (HRP), with a slight shift in the 430 nm peak confirming successful chemical modification .

How does the periodate method work for conjugating HRP to antibodies?

The periodate method is the most commonly used approach for HRP conjugation. The process involves:

  • Oxidation of carbohydrate moieties on HRP using sodium meta-periodate (NaIO₄) to generate reactive aldehyde groups

  • Removal of excess periodate through dialysis against phosphate-buffered saline

  • Reaction of the activated HRP with amino groups on the antibody to form Schiff bases

  • Stabilization of these bonds using sodium cyanoborohydride

  • Final dialysis to remove unreacted components

This classical approach typically employs a 1:4 molar ratio of antibody to HRP (approximately 1:1 by mass). The process creates stable covalent linkages between the molecules without significantly affecting their respective functions .

How does lyophilization enhance HRP-antibody conjugation?

Lyophilization (freeze-drying) of activated HRP before combining it with antibodies has been shown to significantly improve conjugation efficiency and enhance the sensitivity of the resulting conjugate. According to research by Regidi et al., this modified approach involves:

  • Activating HRP with sodium metaperiodate

  • Dialyzing against PBS

  • Freezing at -80°C for 5-6 hours

  • Lyophilizing overnight

  • Mixing with antibody (1 mg/ml concentration)

  • Incubating at 37°C for 1 hour

  • Adding sodium cyanoborohydride for Schiff's base reaction

  • Final dialysis against PBS

The enhanced method produced conjugates that retained activity at dilutions of 1:5000, while classical methods required much lower dilutions (1:25) to detect the same amount of antigen (p<0.001). The increased sensitivity is attributed to the ability of antibodies to bind more HRP molecules due to the reduced reaction volume achieved through lyophilization, which increases collision frequency between reactant molecules without changing their amounts .

What factors influence the efficiency of HRP-antibody conjugation?

Several critical factors affect conjugation efficiency:

  • Antibody concentration: Typically 1 mg/ml is optimal for consistent conjugation

  • Molar ratio: The standard ratio of antibody to HRP is 1:4, which balances adequate labeling with preservation of antibody function

  • Oxidation conditions: Temperature, time, and periodate concentration affect the degree of aldehyde generation on HRP

  • pH: Conjugation reactions are typically performed at neutral pH (around 7.4) for optimal Schiff base formation

  • Lyophilization step: Inclusion of this step significantly enhances conjugation by concentrating reactants

  • Reaction time and temperature: These parameters must be optimized to ensure complete conjugation without denaturing proteins

  • Stabilization chemistry: Proper reduction using sodium cyanoborohydride is essential for stable bonds

How does the sensitivity of TES antibody, HRP conjugated compare to other detection systems?

HRP-conjugated antibodies, including TES antibodies, generally offer excellent sensitivity in immunoassays. When specifically examining enhanced conjugation methods for HRP-antibodies:

  • Direct ELISA tests demonstrated that enhanced lyophilization-based conjugation methods allowed detection at dilutions of 1:5000, compared to only 1:25 for classical methods (p<0.001)

  • Enhanced methods could detect antigen concentrations as low as 1.5 ng

  • SDS-PAGE and UV spectrophotometry confirmed successful conjugation with both methods

Compared to alkaline phosphatase (another common enzyme label), HRP is generally smaller in size (44 kDa vs ~140 kDa), less expensive, produces faster reactions, and exhibits greater stability, particularly in phosphate-based buffers .

What are the optimal substrates for TES antibody, HRP conjugated in different detection systems?

HRP catalyzes the reaction between hydrogen peroxide and various substrates to generate detectable signals. Optimal substrate selection depends on the specific application:

  • Colorimetric detection (for ELISA, IHC):

    • 3,3'-Diaminobenzidine (DAB): Produces a brown precipitate, ideal for tissue staining

    • 3-Amino-9-ethylcarbazole (AEC): Yields a red precipitate

    • Tetramethylbenzidine (TMB): Produces blue color, preferred for ELISA

    • 4-Chloro-1-naphthol: Generates blue color

  • Chemiluminescent detection (for Western blots):

    • Luminol-based substrates: Provide high sensitivity for detection of low-abundance proteins

    • Enhanced chemiluminescence (ECL) systems: Commercially available kits optimize signal generation

  • For lateral flow assays:

    • Chromogenic substrates that produce rapid, stable color changes

    • Some advanced systems use palladium nanoparticle-HRP combinations for 5-10 fold higher sensitivity than gold nanoparticle systems

How can non-specific background be minimized when using TES antibody, HRP conjugated?

Background signals can compromise assay specificity. Several strategies can reduce non-specific background:

  • For tissue sections (IHC/IF):

    • Pre-treat samples with hydrogen peroxide to exhaust endogenous peroxidase-like enzymes

    • Implement appropriate blocking steps using bovine serum albumin, normal serum, or commercial blocking reagents

    • Include washing steps with detergent-containing buffers (0.05-0.1% Tween-20)

    • Optimize antibody concentration through titration experiments

  • For Western blots:

    • Ensure adequate blocking (5% non-fat milk or 3-5% BSA)

    • Use optimized dilution of HRP-conjugated antibody

    • Include detergent in wash buffers

    • Consider specialized low-background membranes

  • For ELISA:

    • Optimize coating concentration and blocking

    • Determine optimal conjugate dilution through checker-board titration

    • Use high-quality purified antibodies for conjugation

    • Include appropriate negative controls

How should HRP-conjugated antibodies be stored to maintain optimal activity?

Proper storage is critical for maintaining the activity of HRP-conjugated antibodies:

  • Short-term storage (up to 6 months):

    • Store at 4°C with appropriate preservatives

    • Addition of stabilizers (e.g., 50% glycerol, BSA) helps maintain activity

    • Avoid repeated freeze-thaw cycles

  • Long-term storage:

    • Store at -20°C or -80°C in small aliquots

    • Addition of cryoprotectants like glycerol (final concentration 30-50%)

    • Some commercial preparations include 0.03% Proclin 300 as a preservative

  • Avoid:

    • Exposure to strong light

    • Prolonged exposure to room temperature

    • Contamination with microorganisms

    • Repeated freeze-thaw cycles

How can TES antibody, HRP conjugated be used for multiplex detection systems?

For advanced multiplex detection using HRP-conjugated antibodies:

  • Sequential multiplex immunohistochemistry:

    • Apply first HRP-conjugated antibody and develop with a substrate

    • Implement HRP inactivation step (e.g., sodium azide treatment)

    • Apply second HRP-conjugated antibody with a different substrate

    • This allows visualization of multiple targets on the same sample

  • Indirect multiplex methods:

    • Use different primary antibodies from different host species

    • Apply species-specific HRP-conjugated secondary antibodies sequentially

    • Develop with different substrates for differential visualization

  • Advanced lateral flow multiplex systems:

    • Multiple test lines with different capture antibodies

    • Use of HRP conjugates that provide strong signal amplification

What are the considerations for using TES antibody, HRP conjugated in quantitative applications?

For quantitative applications using HRP-conjugated TES antibodies:

  • Standard curve preparation:

    • Use purified TES antigens at known concentrations

    • Include sufficient concentration points for accurate interpolation

    • Ensure consistency in reagent preparation and incubation times

  • Signal measurement optimization:

    • For colorimetric detection, measure absorbance at the appropriate wavelength for the substrate used

    • For chemiluminescent detection, optimize exposure time to prevent signal saturation

    • Implement appropriate curve-fitting models (4-parameter logistic preferred for ELISA)

  • Assay validation parameters:

    • Determine lower and upper limits of quantification

    • Assess intra-assay and inter-assay precision (%CV typically <10% for reliable quantification)

    • Evaluate linearity, recovery, and parallelism

    • Test for potential interfering substances in sample matrix

Research by Regidi et al. demonstrated that enhanced conjugation methods allowed detection of antigens at concentrations as low as 1.5 ng, with significant improvements in dilution response curves compared to classical methods .

How are direct HRP-conjugated primary antibodies changing detection workflows?

Direct HRP-conjugated primary antibodies are streamlining detection workflows in several ways:

  • Time reduction: A study examining anti-EPO antibodies directly conjugated to HRP showed reduction in analysis time from 25 hours (two-step approach) to just 7 hours (direct approach)

  • Elimination of cross-reactivity: Direct conjugation removes potential cross-reactivity issues associated with secondary antibodies, which is particularly advantageous in multiplex detection systems

  • Commercial availability: Increasing availability of direct HRP-conjugation kits (like Lightning-Link®) allow researchers to create conjugates with minimal hands-on time (~30 seconds) and complete recovery of antibody for use in various applications

What novel conjugation chemistries are being developed for improved HRP-antibody performance?

Beyond the classical periodate method, several alternative conjugation approaches are being explored:

  • Heterobifunctional cross-linkers: Use of Sulfo-SMCC to generate maleimide-activated HRP that reacts with sulfhydryl groups introduced into antibodies via SATA-mediated thiolation

  • Site-specific conjugation: Methods targeting specific sites on antibodies rather than random amine groups, resulting in more homogeneous conjugates with improved functional properties

  • Click chemistry approaches: Using bioorthogonal reactions for highly specific conjugation under mild conditions

  • Enzyme engineering: Modified HRP variants with improved stability and catalytic efficiency for enhanced detection sensitivity

  • Nanoparticle-mediated conjugation: Development of systems incorporating HRP onto nanoparticles for signal amplification, as seen in advanced lateral flow assays using palladium nanoparticle-HRP combinations that show 5-10 fold higher sensitivity

How can the quality of TES antibody, HRP conjugated be assessed before experimental use?

Multiple analytical methods can verify successful conjugation and activity:

  • UV-visible spectroscopy:

    • Unconjugated HRP shows a peak at 430 nm

    • Unconjugated antibody shows a peak at 280 nm

    • Successful conjugates show peaks at both wavelengths, with a characteristic shift in the 430 nm peak due to chemical modification

  • SDS-PAGE analysis:

    • Conjugates show reduced mobility compared to unconjugated components

    • Non-reducing and reducing conditions can be compared to assess structural integrity

  • Functional testing:

    • Direct ELISA against known antigens

    • Titration experiments to determine optimal working dilution

    • Comparison with reference standards or previous conjugate batches

  • Rapid test strip methods:

    • Commercial kits like the HRP Antibody Conjugation Check Kit (ab236555) provide nitrocellulose strips with immobilized Protein A/G test lines

    • Application of diluted conjugate (0.5-10 ng/mL) followed by HRP detection solution produces visible signal confirming active conjugate

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.